Your browser doesn't support javascript.
loading
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL.
Shetty, Dhanlaxmi; Amare, Pratibha Kadam; Mohanty, Purvi; Talker, Elizabeth; Chaubal, Kruti; Jain, Hemani; Tembhare, Prashant; Patkar, Nikhil; Chaturvedi, Anumeha; Subramanian, P G; Moulik, Nirmalya; Dhamne, Chetan; Jain, Hasmukh; Bagal, Bhausaheb; Narula, Gaurav; Sengar, Manju; Khattry, Navin; Banavali, Shripad.
Afiliación
  • Shetty D; Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India. Electronic address: shettydl@tmc.gov.in.
  • Amare PK; Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India.
  • Mohanty P; Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India.
  • Talker E; Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India.
  • Chaubal K; Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India.
  • Jain H; Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India.
  • Tembhare P; Department of Hematopathology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Patkar N; Department of Hematopathology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Chaturvedi A; Department of Hematopathology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India.
  • Subramanian PG; Department of Hematopathology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Moulik N; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Dhamne C; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Jain H; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Bagal B; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Narula G; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Sengar M; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Khattry N; Department of Medical Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
  • Banavali S; Department of Medical Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai, India; Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, India.
Blood Cells Mol Dis ; 85: 102465, 2020 11.
Article en En | MEDLINE | ID: mdl-32693366
Ploidy, besides known translocations in lymphoblasts, is a strong predictor of prognosis in B- cell progenitor acute lymphoblastic leukemia (BCP-ALL). While hyperdiploidy with >50 chromosomes shows a favourable outcome, hypodiploidy with <45 chromosomes have a dismal clinical outcome. However, there exists a small subset where both the hypodiploid and hyperdiploid clones are apparent either by cytogenetics or flow cytometry and are defined partially masked hypodiploids or mosaics based on the percentage of clonal population. These patients are essentially hypodiploids, and show the hyperdiploid clone as a consequence of endoreduplication of the primary hypodiploid clone- A phenomenon of successive replication of genome without mitosis (cytokinesis) resulting in increased ploidy. In the current study, we present the complete clinical, hematological and cytogenetic profile of 11 such newly diagnosed mosaics or partially masked hypodiploid BCP-ALL cases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Blood Cells Mol Dis Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Blood Cells Mol Dis Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article